Literature DB >> 29260195

Diabetic Retinopathy and Macular Edema Quality-of-Life Item Banks: Development and Initial Evaluation Using Computerized Adaptive Testing.

Eva K Fenwick1,2,3, Jyoti Khadka4, Konrad Pesudovs4, Gwyn Rees1, Tien Y Wong2,3, Ecosse L Lamoureux1,2,3.   

Abstract

Purpose: The purpose of this study was to assess the psychometric properties of diabetic retinopathy (DR) and diabetic macular edema (DME) quality-of-life (QoL) item banks and determine the utility of the final calibrated item banks by simulating a computerized adaptive testing (CAT) application.
Methods: In this clinical, cross-sectional study, 514 participants with DR/DME (mean age ± SD, 60.4 ± 12.6 years; 64% male) answered 314 items grouped under nine QoL item pools: Visual Symptoms (SY); Ocular Comfort Symptoms (OS); Activity Limitation (AL); Mobility (MB); Emotional (EM); Health Concerns (HC); Social (SC); Convenience (CV); and Economic (EC). The psychometric properties of the item pools were assessed using Rasch analysis, and CAT simulations determined the average number of items administered at high and moderate precision levels.
Results: The SY, MB, EM, and HC item pools required minor amendments, mainly involving removal of six poorly worded, highly misfitting items. AL and CV required substantial modification to resolve multidimensionality, which resulted in two new item banks: Driving (DV) and Lighting (LT). Due to unresolvable psychometric issues, the OS, SC, and EC item pools were not pursued further. This iterative process resulted in eight operational item banks that underwent CAT simulations. Correlations between CAT and the full item banks were high (range, 0.88-0.99). On average, only 3.6 and 7.2 items were required to gain measurement at moderate and high precision, respectively. Conclusions: Our eight psychometrically robust and efficient DR/DME item banks will enable researchers and clinicians to accurately assess the impact and effectiveness of treatment therapies for DR/DME in all areas of QoL.

Entities:  

Mesh:

Year:  2017        PMID: 29260195     DOI: 10.1167/iovs.16-20950

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains.

Authors:  Preeti Gupta; Eva K Fenwick; Ryan E K Man; Alfred T L Gan; Charumathi Sabanayagam; Debra Quek; Chaoxu Qian; Chui Ming Gemmy Cheung; Ching-Yu Cheng; Ecosse L Lamoureux
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

2.  Psychometric Evaluation of Glaucoma Quality of Life Item Banks (GlauCAT) and Initial Assessment Using Computerized Adaptive Testing.

Authors:  Ryan Eyn Kidd Man; Eva K Fenwick; Jyoti Khadka; ZhiChao Wu; Simon Skalicky; Konrad Pesudovs; Ecosse L Lamoureux
Journal:  Transl Vis Sci Technol       Date:  2022-06-01       Impact factor: 3.048

3.  Patient-Reported Symptoms Demonstrating an Association with Severity of Visual Field Damage in Glaucoma.

Authors:  Yesha S Shah; Michael Cheng; Aleksandra Mihailovic; Eva Fenwick; Ecosse Lamoureux; Pradeep Y Ramulu
Journal:  Ophthalmology       Date:  2021-10-28       Impact factor: 14.277

Review 4.  The relationship between diabetic retinopathy and psychosocial functioning: a systematic review.

Authors:  Krystal Khoo; Ryan E K Man; Gwyn Rees; Preeti Gupta; Ecosse L Lamoureux; Eva K Fenwick
Journal:  Qual Life Res       Date:  2019-03-16       Impact factor: 4.147

5.  Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial.

Authors:  Farhad Fazel; Hossein Nikpour; Mohsen Pourazizi
Journal:  Biomed Res Int       Date:  2020-01-16       Impact factor: 3.411

6.  Calibration of the Dutch EyeQ to Measure Vision Related Quality of Life in Patients With Exudative Retinal Diseases.

Authors:  T Petra Rausch-Koster; Michiel A J Luijten; F D Verbraak; Ger H M B van Rens; Ruth M A van Nispen
Journal:  Transl Vis Sci Technol       Date:  2022-04-01       Impact factor: 3.283

7.  Computerized Adaptive Tests: Efficient and Precise Assessment of the Patient-Centered Impact of Diabetic Retinopathy.

Authors:  Eva K Fenwick; John Barnard; Alfred Gan; Bao Sheng Loe; Jyoti Khadka; Konrad Pesudovs; Ryan Man; Shu Yen Lee; Gavin Tan; Tien Y Wong; Ecosse L Lamoureux
Journal:  Transl Vis Sci Technol       Date:  2020-06-03       Impact factor: 3.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.